Integer Holdings (ITGR) Change in Accured Expenses (2010 - 2026)
Integer Holdings (ITGR) reported Change in Accured Expenses of -$30.6 million for Q2 2026, down 30.44% on a YoY basis from -$44.1 million in Q2 2025, and down 1566.36% sequentially from $2.1 million in Q4 2025.
Integer Holdings (ITGR) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Change in Accured Expenses data on file, last reported at -$30.6 million in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses fell 30.44% year-over-year to -$30.6 million; the trailing twelve-month figure through Apr 2026 stood at -$27.4 million (down 914133.33% YoY), and the FY2025 full-year result was -$20.3 million, down 553.24% from the prior year.
- Change in Accured Expenses declined to -$30.6 million in Q2 2026, from $2.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $10.8 million in Q3 2024 to a low of -$30.6 million in Q2 2026.
- A 5-year average of -$2.8 million and a median of $507000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 1838.26% in 2024, while the deepest fall reached 144.77% in 2024.
- Tracing ITGR's Change in Accured Expenses over 5 years: stood at -$3.5 million in 2022, then soared by 114.42% to $507000.0 in 2023, then soared by 1838.26% to $9.8 million in 2024, then tumbled by 78.73% to $2.1 million in 2025, then slumped by 1566.36% to -$30.6 million in 2026.
- Business Quant data shows ITGR's Change in Accured Expenses at -$30.6 million in Q2 2026, $2.1 million in Q4 2025, and $953000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integer Holdings | 3.34 Bn | 3.33 Bn | 109.60 Mn | -30.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -30.65 Mn |
| Apr 3, 2026 | -30.65 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Sep 26, 2025 | 953,000.00 |
| Sep 26, 2025 | 953,000.00 |
| Jun 27, 2025 | 183,000.00 |
| Jun 27, 2025 | 183,000.00 |
| Mar 28, 2025 | -23.50 Mn |
| Mar 28, 2025 | -23.50 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Sep 27, 2024 | 10.80 Mn |
| Sep 27, 2024 | 10.80 Mn |
| Jun 28, 2024 | 2.87 Mn |
| Jun 28, 2024 | 2.87 Mn |
| Mar 29, 2024 | -19.03 Mn |
| Mar 29, 2024 | -19.03 Mn |
| Dec 31, 2023 | 507,000.00 |
| Dec 31, 2023 | 507,000.00 |